HALEOS LABS
Back to Balance Sheet
|
HALEOS LABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹36 Cr | ₹52 Cr | ₹73 Cr | ₹56 Cr | ₹59 Cr |
What is the latest Total Non-Current Liabilities ratio of HALEOS LABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹36 Cr |
| Mar2024 | ₹52 Cr |
| Mar2023 | ₹73 Cr |
| Mar2022 | ₹56 Cr |
| Mar2021 | ₹59 Cr |
How is Total Non-Current Liabilities of HALEOS LABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹36 Cr | -31.43 | |
| Mar2024 | ₹52 Cr | -28.43 | |
| Mar2023 | ₹73 Cr | 29.68 | |
| Mar2022 | ₹56 Cr | -4.45 | |
| Mar2021 | ₹59 Cr | - | |
Compare Total Non-Current Liabilities of peers of HALEOS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HALEOS LABS | ₹473.0 Cr | -0% | 11.4% | 19.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,644.0 Cr | 1.1% | 7.2% | 15.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹184,053.0 Cr | 2.4% | 4.2% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹167,464.0 Cr | 1.9% | 8.3% | 45.6% | Stock Analytics | |
| CIPLA | ₹115,263.0 Cr | -1.8% | 3.2% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,049.0 Cr | -8.8% | -3.2% | -4.6% | Stock Analytics | |
HALEOS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HALEOS LABS | -0% |
11.4% |
19.6% |
| SENSEX | -0.9% |
4.9% |
-6.8% |
You may also like the below Video Courses